Nashville — Nashville, Tennessee

Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Nashville has participated in 11 clinical trials.

Therapeutic areas: Non Small Cell Lung Cancer Metastatic, Clostridium Difficile Infection Recurrence, Dry Eye Disease.

Sponsors: Transgene, Finch Research and Development LLC., Oyster Point Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville?

Nashville has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville conducted?

Nashville has 11 clinical trials on record. Their work covers Non Small Cell Lung Cancer Metastatic, Clostridium Difficile Infection Recurrence, Dry Eye Disease.

Is Nashville accredited by Crixeo Health?

Yes — Nashville holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.